Market Research Logo

Global Nanocapsule Market Insights, Opportunity Analysis, Market Shares and Forecast 2017 - 2023

Global Nanocapsule Market Insights, Opportunity Analysis, Market Shares and Forecast 2017 - 2023

Nano capsules are nano particles that consists of a shell and space in which drug molecules are embedded. The global nano capsule is expected to grow with a CAGR of XX% during the forecast period of 2016-2023.Nano capsules find its applications in healthcare, food science, genetic engineering, cosmetics, cleansing products, agriculture, agrochemicals etc. Increasing prevalence of chronic diseases is adding growth in the global nano capsules market during the forecast period. However, nano capsule targets only the pre-determines areas and is considered as one of the restraining factor in the growth of global nano capsules market during the forecast period.

Geographically, North America accounted for the largest market share in terms of revenue in 2016 and the region is expected to dominate the global nano capsules market during the forecast period. The growth during the forecast period is attributed by increasing investments and research and development activities and highly effective improved therapies involving the use of nano capsules in the region. Also, increasing applications in various sectors such as genetic engineering, cosmetics, cleansing products etc are adding growth in the nano capsules market in the region during the forecast period. Moreover, Asia pacific is expected to be the fastest growing region in nano capsules market during the forecast period owing to increase in pharmaceutical industries in the region.

The growth in global nano capsules market is also influenced by the presence of major players such as Bio Delivery Sciences (U.S.), Camurus (Sweden), Carlina Technologies (France), Cerulean Pharma Inc. (U.S.), Nano Green Sciences Inc. (U.S.), Nanonutra etc. Some crucial strategies adopted by the major players product launches, mergers & acquisitions etc. These strategies are adopted by the market players to gain competitive advantage.

The global nano capsules market has been segmented on the basis of therapy areas and applications of nano capsules. Market report further covers segmentation analysis of therapy areas which includes Oncology, Pain management, Endocrinology and other therapy areas. Oncology accounted for the largest market share in terms of revenue in 2016. Nano capsules carry anti-cancer agents and deposit them targeting tumor cells to cure cancer. Increasing cancer cases worldwide have developed new methods to control the incidence rates therefore growth is observed in oncology segment of nano capsules market. Furthermore, the applications of the global nano capsules market can be divided as Healthcare, Food and neutraceuticals, cosmetics, agriculture production and other application areas of nano capsules. Healthcare segment accounted for the largest market share in terms of revenue in 2016. Growth in healthcare segment is witnessed due to efficient drug targeting of nano capsules.

Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.


1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
2. MARKET OVERVIEW
2.1. NANO CAPSULES MARKET: EVOLUTION & TRANSITION
2.2. MARKET DEFINITION & SCOPE
2.3. INDUSTRY STRUCTURE
2.4. REGULATORY FRAMEWORK
2.5. TOTAL MARKET ANALYSIS
2.5.1. TOP 5 FINDINGS
2.5.2. TOP 5 OPPORTUNITY MARKETS
2.5.3. TOP 5 COMPANIES
2.5.4. TOP 3 COMPETITIVE STRATEGIES
2.6. ESTIMATION ANALYSIS
2.7. STRATEGIC ANALYSIS
2.7.1. INVESTMENT VS. ADOPTION MODEL
2.7.2. 360-DEGREE INDUSTRY ANALYSIS
2.7.3. PORTERS 5 FORCE MODEL
2.7.4. SEE-SAW ANALYSIS
2.7.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.8. COMPETITIVE ANALYSIS
2.8.1. KEY STRATEGIES & ANALYSIS
2.8.2. MARKET SHARE ANALYSIS AND TOP COMPANY ANALYSIS
2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
3. MARKET DETERMINANTS
3.1. MARKET DRIVERS
3.1.1. INCREASING PREVALANCE OF CHRONIC DISEASES
3.1.2. INCREASED INVESTMENT BY MARKET PLAYERS IN RESEARCH AND COMMERCIALIZATION
3.1.3. RISING PHARMACEUTICAL INDUSTRY
3.1.4. INCREASING ADOPTION OF NANOTECHNOLOGY GLOBALLY
3.1.5. INCREASING DEMAND FOR NANOCAPSULES IN HEALTHCARE
3.2. MARKET RESTRAINTS
3.2.1. INCREASING HAZARDS DUE TO ENGINEERED NANOPARTICLES
3.2.2. TARGET ONLY PREDETERMINED AREAS
3.3. MARKET OPPORTUNITIES
3.3.1. DEVELOPMENT IN THE FIELD OF ENDOCRINILOGY
3.3.2. INCREASING APPLICATION IN COSMETIC SECTOR
3.4. MARKET CHALLENGES
3.4.1. LACK OF AWARENESS REGARDING BENEFITS OF NANOCAPSULES
4. MARKET SEGMENTATION
4.1. NANOCAPSULES MARKET BY THERAPY AREA
4.1.1. MARKET DEFINITION AND SCOPE
4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.1.4. OPPORTUNITY MATRIX
4.1.5. MARKET SEGMENTATION
4.1.5.1. GLOBAL ONCOLOGY MARKET
4.1.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.1.3. TOP PLAYERS & KEY PRODUCTS
4.1.5.1.4. KEY CONCLUSIONS
4.1.5.2. GLOBAL PAIN MANAGEMENT MARKET
4.1.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.2.3. TOP PLAYERS & KEY PRODUCTS
4.1.5.2.4. KEY CONCLUSIONS
4.1.5.3. GLOBAL ENDOCRINOLOGY MARKET
4.1.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.3.3. TOP PLAYERS & KEY PRODUCTS
4.1.5.3.4. KEY CONCLUSIONS
4.1.5.4. GLOBAL OTHERS MARKET
4.1.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.4.3. TOP PLAYERS & KEY PRODUCTS
4.1.5.4.4. KEY CONCLUSIONS
4.2. NANOCAPSULES MARKET BY APPLICATION
4.2.1. MARKET DEFINITION AND SCOPE
4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.2.4. OPPORTUNITY MATRIX
4.2.5. MARKET SEGMENTATION
4.2.5.1. GLOBAL HEALTHCARE MARKET
4.2.5.1.1. APPLICATION
4.2.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.1.5. KEY CONCLUSIONS
4.2.5.2. GLOBAL FOOD AND NUTRACEUTICALS MARKET
4.2.5.2.1. APPLICATION
4.2.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.2.5. KEY CONCLUSIONS
4.2.5.3. GLOBAL COSMETICS MARKET
4.2.5.3.1. APPLICATION
4.2.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.3.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.3.5. KEY CONCLUSIONS
4.2.5.4. GLOBAL AGRICULTURE PRODUCTION MARKET
4.2.5.4.1. APPLICATION
4.2.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.4.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.4.5. KEY CONCLUSIONS
4.2.5.5. GLOBAL OTHERS MARKET
4.2.5.5.1. APPLICATION
4.2.5.5.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.5.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.5.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.5.5. KEY CONCLUSIONS
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.1.1. LIST OF MERGERS AND ACQUISITION
5.1.2. LIST OF JOINT VENTURES
5.1.3. LIST OF PRODUCT LAUNCHES
5.1.4. LIST OF PARTNERSHIPS
6. GEOGRAPHICAL ANALYSIS
6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.3. OPPORTUNITY MATRIX
6.4. GLOBAL NANOCAPSULES MARKET BY REGION 2014-2023 ($ MILLION)
6.4.1. NORTH AMERICA
6.4.1.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.1.2. TOP COUNTRY ANALYSIS
6.4.1.2.1. U.S.
6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.1.2.1.3. KEY CONCLUSIONS
6.4.1.2.2. CANADA
6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.1.2.2.3. KEY CONCLUSIONS
6.4.2. EUROPE
6.4.2.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.2.2. TOP COUNTRY ANALYSIS
6.4.2.2.1. UK
6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.1.3. KEY CONCLUSIONS
6.4.2.2.2. FRANCE
6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.2.3. KEY CONCLUSIONS
6.4.2.2.3. GERMANY
6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.3.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.3.3. KEY CONCLUSIONS
6.4.2.2.4. SPAIN
6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.4.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.4.3. KEY CONCLUSIONS
6.4.2.2.5. REST OF EUROPE
6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.5.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.5.3. KEY CONCLUSIONS
6.4.3. ASIA PACIFIC
6.4.3.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.3.2. TOP COUNTRY ANALYSIS
6.4.3.2.1. CHINA
6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.1.3. KEY CONCLUSIONS
6.4.3.2.2. INDIA
6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.2.3. KEY CONCLUSIONS
6.4.3.2.3. JAPAN
6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.3.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.3.3. KEY CONCLUSIONS
6.4.3.2.4. AUSTRALIA
6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.4.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.4.3. KEY CONCLUSIONS
6.4.3.2.5. REST OF ASIA PACIFIC
6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.5.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.5.3. KEY CONCLUSIONS
6.4.4. ROW
6.4.4.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
6.4.4.2. TOP COUNTRY ANALYSIS
6.4.4.2.1. LATIN AMERICA
6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.4.2.1.3. KEY CONCLUSIONS
6.4.4.2.2. MIDDLE EAST & AFRICA
6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.4.2.2.3. KEY CONCLUSIONS
7. COMPANY PROFILES
7.1. BIO DELIVERY SCINCES (U.S.)
7.1.1. OVERVIEW
7.1.2. PRODUCT PORTFOLIO
7.1.3. KEY INNOVATION SECTOR
7.1.4. STRATEGIC INITIATIVES
7.1.5. SCOT ANALYSIS
7.1.6. STRATEGIC ANALYSIS
7.2. CAMURUS (SWEDEN)
7.2.1. OVERVIEW
7.2.2. PRODUCT PORTFOLIO
7.2.3. KEY INNOVATION SECTOR
7.2.4. STRATEGIC INITIATIVES
7.2.5. SCOT ANALYSIS
7.2.6. STRATEGIC ANALYSIS
7.3. CARLINA TECHNOLOGIES (FRANCE)
7.3.1. OVERVIEW
7.3.2. PRODUCT PORTFOLIO
7.3.3. KEY INNOVATION SECTOR
7.3.4. STRATEGIC INITIATIVES
7.3.5. SCOT ANALYSIS
7.3.6. STRATEGIC ANALYSIS
7.4. CERULEAN PHARMA INC. (U.S.)
7.4.1. OVERVIEW
7.4.2. PRODUCT PORTFOLIO
7.4.3. KEY INNOVATION SECTOR
7.4.4. STRATEGIC INITIATIVES
7.4.5. SCOT ANALYSIS
7.4.6. STRATEGIC ANALYSIS
7.5. NANO GREEN SCIENCES INC. (U.S.)
7.5.1. OVERVIEW
7.5.2. PRODUCT PORTFOLIO
7.5.3. KEY INNOVATION SECTOR
7.5.4. STRATEGIC INITIATIVES
7.5.5. SCOT ANALYSIS
7.5.6. STRATEGIC ANALYSIS
7.6. NANONUTRA
7.6.1. OVERVIEW
7.6.2. PRODUCT PORTFOLIO
7.6.3. KEY INNOVATION SECTOR
7.6.4. STRATEGIC INITIATIVES
7.6.5. SCOT ANALYSIS
7.6.6. STRATEGIC ANALYSIS
7.7. NANOSPHERE HEALTH SCIENCE (U.S.)
7.7.1. OVERVIEW
7.7.2. PRODUCT PORTFOLIO
7.7.3. KEY INNOVATION SECTOR
7.7.4. STRATEGIC INITIATIVES
7.7.5. SCOT ANALYSIS
7.7.6. STRATEGIC ANALYSIS
7.8. EOS BIO SCIENCES INC. (U.S.)
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. KEY INNOVATION SECTOR
7.8.4. STRATEGIC INITIATIVES
7.8.5. SCOT ANALYSIS
7.8.6. STRATEGIC ANALYSIS
7.9. LOREAL (FRANCE)
7.9.1. OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. KEY INNOVATION SECTOR
7.9.4. STRATEGIC INITIATIVES
7.9.5. SCOT ANALYSIS
7.9.6. STRATEGIC ANALYSIS
7.10. GAT FOOD ESSENTIALS (AUSTRIA)
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. KEY INNOVATION SECTOR
7.10.4. STRATEGIC INITIATIVES
7.10.5. SCOT ANALYSIS
7.10.6. STRATEGIC ANALYSIS
7.11. THERAPY AREA BENCHMARKING (U.S.)
7.11.1. OVERVIEW
7.11.2. PRODUCT PORTFOLIO
7.11.3. KEY INNOVATION SECTOR
7.11.4. STRATEGIC INITIATIVES
7.11.5. SCOT ANALYSIS
7.11.6. STRATEGIC ANALYSIS
7.12. PLASMACHEM GMBH (GERMANY)
7.12.1. OVERVIEW
7.12.2. PRODUCT PORTFOLIO
7.12.3. KEY INNOVATION SECTOR
7.12.4. STRATEGIC INITIATIVES
7.12.5. SCOT ANALYSIS
7.12.6. STRATEGIC ANALYSIS
7.13. SINTEF (NORWAY)
7.13.1. OVERVIEW
7.13.2. PRODUCT PORTFOLIO
7.13.3. KEY INNOVATION SECTOR
7.13.4. STRATEGIC INITIATIVES
7.13.5. SCOT ANALYSIS
7.13.6. STRATEGIC ANALYSIS
7.14. BIOPHAN TECHNOLOGIES (U.S.)
7.14.1. OVERVIEW
7.14.2. PRODUCT PORTFOLIO
7.14.3. KEY INNOVATION SECTOR
7.14.4. STRATEGIC INITIATIVES
7.14.5. SCOT ANALYSIS
7.14.6. STRATEGIC ANALYSIS
7.15. OTHERS
7.15.1. OVERVIEW
7.15.2. PRODUCT PORTFOLIO
7.15.3. KEY INNOVATION SECTOR
7.15.4. STRATEGIC INITIATIVES
7.15.5. SCOT ANALYSIS
7.15.6. STRATEGIC ANALYSIS
LIST OF TABLES
GLOBAL NANOCAPSULES MARKET BY THERAPY AREA 2014-2023 ($ MILLION)
GLOBAL ONCOLOGY MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL PAIN MANAGEMENT MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL ENDOCRINOLOGY MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL OTHERS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL NANOCAPSULES MARKET BY APPLICATION 2014-2023 ($ MILLION)
GLOBAL HEALTHCARE MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL FOOD AND NUTRACEUTICALS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL COSMETICS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL AGRICULTURE PRODUCTION MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL OTHERS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
NORTH AMERICA NANOCAPSULES MARKET 2014-2023 ($ MILLION)
EUROPE NANOCAPSULES MARKET 2014-2023 ($ MILLION)
ASIA PACIFIC NANOCAPSULES MARKET 2014-2023 ($ MILLION)
REST OF THE WORLD NANOCAPSULES MARKET 2014-2023 ($ MILLION)
LIST OF FIGURES
GLOBAL NANOCAPSULES MARKET 2014-2023 ($ MILLION)
GLOBAL ONCOLOGY MARKET 2014-2023 ($ MILLION)
GLOBAL PAIN MANAGEMENT MARKET 2014-2023 ($ MILLION)
GLOBAL ENDOCRINOLOGY MARKET 2014-2023 ($ MILLION)
GLOBAL OTHERS MARKET 2014-2023 ($ MILLION)
GLOBAL HEALTHCARE MARKET 2014-2023 ($ MILLION)
GLOBAL FOOD AND NUTRACEUTICALS MARKET 2014-2023 ($ MILLION)
GLOBAL COSMETICS MARKET 2014-2023 ($ MILLION)
GLOBAL AGRICULTURE PRODUCTION MARKET 2014-2023 ($ MILLION)
GLOBAL OTHERS MARKET 2014-2023 ($ MILLION)
UNITED STATES (U.S.) NANO CAPSULES MARKET 2014-2023 ($ MILLION)
CANADA NANO CAPSULES MARKET 2014-2023 ($ MILLION)
UNITED KINGDOM (UK) NANOCAPSULES MARKET 2014-2023 ($ MILLION)
FRANCE NANOCAPSULES MARKET 2014-2023 ($ MILLION)
GERMANY NANOCAPSULES MARKET 2014-2023 ($ MILLION)
SPAIN NANOCAPSULES MARKET 2014-2023 ($ MILLION)
ROE NANOCAPSULES MARKET 2014-2023 ($ MILLION)
INDIA NANOCAPSULES MARKET 2014-2023 ($ MILLION)
CHINA NANOCAPSULES MARKET 2014-2023 ($ MILLION)
JAPAN NANOCAPSULES MARKET 2014-2023 ($ MILLION)
AUSTRALIA NANOCAPSULES MARKET 2014-2023 ($ MILLION)
ROAPAC NANOCAPSULES MARKET 2014-2023 ($ MILLION)
LATIN AMERICA NANOCAPSULES MARKET 2014-2023 ($ MILLION)
MENA NANOCAPSULES MARKET 2014-2023 ($ MILLION)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report